Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

JT010

Copy Product Info
🥰Excellent
Catalog No. T15628Cas No. 917562-33-5

JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).

JT010

JT010

Copy Product Info
🥰Excellent
Purity: 99.75%
Catalog No. T15628Cas No. 917562-33-5
JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$29In StockIn Stock
5 mg$48In StockIn Stock
10 mg$77In StockIn Stock
25 mg$158In StockIn Stock
50 mg$253In StockIn Stock
100 mg$377In StockIn Stock
1 mL x 10 mM (in DMSO)$53In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.75%
Appearance:Solid
Color:Orange
Contact us for more batch information

Resource Download

Product Introduction

JT010 AI Summary
JT010 shows a slight and insignificant inhibition (-0.2%) of the SARS-CoV-2 3CL-Pro protease at a concentration of 20µM. Additionally, it exhibits antiviral activity by inhibiting SARS-CoV-2 induced cytotoxicity in VERO-6 cells at a concentration of 10µM after 48 hours exposure to 0.01 MOI SARS-CoV-2 virus, with an inhibition rate of -0.3%, as determined by high content imaging. Furthermore, JT010 demonstrates cytotoxic activity against human HepG2 cells, with an IC50 value of 1500.0 nM as assessed by the CellTiter-Glo luminescent cell viability assay..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
JT010 is an effective agonist of TRPA1 (EC50 = 0.65 nM).
Targets&IC50
TRPA1:0.65 nM (EC50)
Chemical Properties
Molecular Weight354.85
FormulaC16H19ClN2O3S
Cas No.917562-33-5
SmilesCOCCCN(C(=O)CCl)c1nc(cs1)-c1ccc(OC)cc1
Relative Density.1.265 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (140.9 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.8181 mL14.0905 mL28.1809 mL140.9046 mL
5 mM0.5636 mL2.8181 mL5.6362 mL28.1809 mL
10 mM0.2818 mL1.4090 mL2.8181 mL14.0905 mL
20 mM0.1409 mL0.7045 mL1.4090 mL7.0452 mL
50 mM0.0564 mL0.2818 mL0.5636 mL2.8181 mL
100 mM0.0282 mL0.1409 mL0.2818 mL1.4090 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy JT010 | purchase JT010 | JT010 cost | order JT010 | JT010 chemical structure | JT010 formula | JT010 molecular weight